hashimotos thyroiditis also known chronic lymphocytic thyroiditis hashimotos disease autoimmune disease thyroid gland gradually slightly broader term autoimmune thyroiditis identical also used describe similar condition without early symptoms may time thyroid may enlarge forming painless people eventually develop hypothyroidism accompanying weight gain fatigue constipation depression hair loss general many years thyroid typically shrinks potential complications include thyroid furthermore common untreated patients hashimotos develop hypothyroidism complications include limited high cholesterol heart disease heart failure high blood pressure myxedema potential pregnancy hashimotos thyroiditis thought due combination genetic environmental risk factors include family history condition another autoimmune diagnosis confirmed blood tests tsh antithyroid conditions produce similar symptoms include graves disease nontoxic nodular hashimotos thyroiditis typically treated hypothyroidism present may recommend treatment others may treat try reduce size affected avoid eating large amounts iodine however sufficient iodine required especially surgery rarely required treat hashimotos thyroiditis affects caucasians point common cause hypothyroidism iodinesufficient areas typically begins ages much common women rates disease appear first described japanese physician hakaru hashimoto recognized autoimmune many symptoms attributed development hashimotos thyroiditis common symptoms include fatigue weight gain pale puffy face feeling cold joint muscle pain constipation dry thinning hair heavy menstrual flow irregular periods depression panic disorder slowed heart rate problems getting pregnant patients early stage disease may experience symptoms hyperthyroidism due release thyroid hormones intermittent thyroid hashimotos disease seven times common women men occur teens young women commonly appears middle age particularly men people develop hashimotos disease often family members thyroid autoimmune diseases sometimes autoimmune diseases early stages autoimmune thyroiditis may normal physical exam without goiter diffuse often symmetric swelling thyroid gland visible anterior neck may thyroid gland may become firm large lobulated hashimotos thyroiditis changes thyroid also enlargement thyroid due lymphocytic infiltration fibrosis rather tissue hypertrophy role initial destruction follicles unclear antibodies thyroid peroxidase thyroglobulin relevant serve markers detecting disease thought secondary products cellmediated destruction lymphocytic infiltration progresses patients may exhibit signs hypothyroidism multiple bodily systems including limited larger goiter weight gain cold intolerance fatigue myxedema constipation menstrual disturbances pale dry skin dry brittle hair depression ataxia muscle patients goiters autoimmune thyroiditis many years might see goiter shrink later stages disease due destruction rare serious complications hypothyroidism resulting autoimmune thyroiditis pericardial effusion pleural effusion require medical attention myxedema coma endocrine autoimmune thyroiditis common cause hypothyroidism settings sufficient estimated affect worlds may affect united states anyone may develop disease autoimmune thyroiditis affects women often men difference prevalence amongst genders due effects sex incidence peaks fifth decade life patients usually diagnosed age thyroid autoimmunity many patients report family history autoimmune thyroiditis graves twin studies revealed concordance hashimotos disease monozygotic autoimmune thyroiditis higher prevalence societies higher intake iodine diet united states japan common cause hypothyroidism areas sufficient also rate lymphocytic infiltration increased areas iodine intake low increased due iodine shown prevalence positive tests thyroid antibodies increases age frequency high percent women years old incidence peaks fifth decade life prevalence increases graves disease may occur development autoimmune patients may also coexisting autoimmune conditions organs may include addison disease type diabetes sjogrens syndrome celiac disease rheumatoid autoimmune thyroiditis also seen patients autoimmune polyendocrine syndromes type strong genetic component borne studies monozygotic twins concordance even higher concordance circulating thyroid antibodies relation clinical presentation monozygotic twins neither result seen similar degree dizygotic twins offering strong favour high genetic certain medications drugs associated altering interfering thyroid function drugs two main mechanisms interference havecitation needed one mechanisms interference drug alters thyroid hormone serum transfer estrogen tamoxifen heroin methadone clofibrate mitotane perphenazine increase thyroid binding globulin tbg androgens anabolic steroids danazol glucocorticoids slow release nicotinic acid decrease tbg concentrations furosemide fenoflenac mefenamic acid salicylates phenytoin diazepam sulphonylureas free fatty acids heparin interfere thyroid hormone binding tbg andor transthyretincitation needed mechanism medications utilize interfere thyroid function would alter extrathryoidal metabolism thyroid hormone propylthiouracil glucocorticoids propranolol iondinated contrast agents amiodarone clomipramine inhibit conversion phenobarbital rifampin phenytoin carbamazepine increase hepatic finally cholestryamine colestipol aluminium hydroxide ferrous sulphate sucralfate drugs decrease absorption enhance first gene locus associated autoimmune thyroid disease major histocompatibility complex mhc region chromosome encodes hlas specific hla alleles higher affinity autoantigenic thyroidal peptides contribute autoimmune thyroid disease development specifically hashimotos disease aberrant expression hla ii thyrocytes demonstrated present thyroid autoantigens initiate autoimmune thyroid susceptibility alleles consistent hashimotos disease caucasians various alleles reported associated disease including gene second major immuneregulatory gene related autoimmune thyroid disease gene polymorphisms may contribute reduced inhibition tcell proliferation increase susceptibility autoimmune major thyroid autoantibody susceptibility gene linkage region presence thyroid autoantibodies demonstrated wholegenome linkage confirmed main locus thyroid recently identified immuneregulatory gene associated autoimmune thyroid disease located chromosome expressed lymphocytes acts negative regulator tcell activation mutation gene risk factor many autoimmune diseases weaker tcell signaling may lead impaired thymic deletion autoreactive cells increased function may result inhibition regulatory cells protect ifnγ promotes cellmediated cytotoxicity thyroid mutations causing increased production ifnγ associated severity severe hypothyroidism associated mutations leading lower production cytokine suppressing cellmediated lower secretion tgfβ inhibitor cytokine mutations essential regulatory factor tregs development hashimotos disease associated mutation gene tnfα stimulator ifnγ production causing higher preventable environmental factors including high iodine intake selenium deficiency infectious diseases certain drugs implicated development autoimmune thyroid disease genetically predisposed excessive iodine intake wellestablished environmental factor triggering thyroid autoimmunity higher prevalence thyroid autoantibodies areas higher iodine supply several mechanisms iodine may promote thyroid autoimmunity proposed iodine exposure leads higher iodination thyroglobulin increasing immunogenicity creating new iodinecontaining epitopes exposing cryptic epitopes may facilitate presentation apc enhance binding affinity tcell receptor activating specific iodine exposure shown increase level reactive oxygen species enhance expression intracellular adhesion thyroid follicular cells could attract immunocompetent cells thyroid iodine toxic thyrocytes since highly reactive oxygen species may bind membrane lipids proteins causes thyrocyte damage release autoantigens iodine also promotes follicular cell apoptosis influence immune cells augmented maturation dendritic cells increased number cells stimulated bcell immunoglobulin data danish investigation iodine intake thyroid disease shows within two cohorts males females moderate mild iodine deficiency levels thyroid peroxidase thyroglobulin antibodies higher females prevalence rates antibodies increase study healthy danish twins divided three groups monozygotic dizygotic sex opposite sex twin pairs estimated genetic contribution thyroid peroxidase antibodies susceptibility males females contribution thyroglobulin antibodies susceptibility males high female predominance thyroid autoimmunity may associated x chromosome contains sex immunerelated genes responsible immune higher incidence thyroid autoimmunity reported patients higher rate xchromosome monosomy peripheral white blood another potential mechanism might skewed xchromosome inactivation leading escape xlinked selfantigens presentation thymus loss tcell tolerancecitation needed autoimmune diseases risk factor developing hashimotos thyroiditis opposite also autoimmune diseases commonly associated hashimotos thyroiditis include celiac disease type diabetes vitiligo genes implicated vary different ethnic groups incidence increased people chromosomal disorders including turner klinefelter syndromes usually associated autoantibodies thyroglobulin thyroperoxidase progressive depletion cells cytotoxic immune response leads higher degrees primary hypothyroidism presenting low levels compensatory elevations tshcitation needed mechanism autoimmune thyroiditis well understood thought develop result complex interaction genetics environmental thyroid autoantibodies appear mostly presence lymphocytes targeted lymphocytes produce antibodies targeting three different thyroid proteins thyroid peroxidase antibodies tpoab thyroglobulin antibodies tgab thyroid stimulating hormone receptor antibodies antibody attacks ultimately lead hypothyroidism caused replacement follicular cells parenchymatous two antibodies commonly implicated autoimmune thyroiditis antibodies thyroid peroxidase tpoab thyroglobulin hypothesized develop result thyroid damage tlymphocytes sensitized residual thyroid peroxidase thyroglobulin rather cause thyroid however may exacerbate thyroid destruction binding complement system triggering apoptosis thyroid environmental factors may predispose patients type immune dysregulation include toxins medications dietary factors infectious patients healthy asymptomatic may positive one antibodies doctors attend patients likely monitor patients chance develop type dysfunction gross morphological changes within thyroid seen general enlargement far locally nodular irregular diffuse patterns hyperthyroidism capsule intact gland still distinct surrounding tissue microscopic examination provide revealing indication level gross pathology thyroid autoimmune thyroiditis may show symmetrically enlarged often paler color comparison normal thyroid tissue microscopic examination show infiltration lymphocytes plasma cells lymphocytes predominately tlymphocytes representation positive positive plasma cells polyclonal present germinal centers resembling structure lymph fibrous tissue may found throughout affected thyroid generally pathological findings thyroid related amount existing thyroid function infiltration fibrosis less likely patient normal thyroid late stages disease thyroid may histologically hypersensitivity seen diffuse parenchymal infiltration lymphocytes particularly plasma bcells often seen secondary lymphoid follicles germinal centers confused normally present colloidfilled follicles constitute thyroid atrophy colloid bodies lined hürthle cells cells intensely eosinophilic granular cytoplasm metaplasia normal cuboidal cells constitute lining thyroid follicles severe thyroid atrophy presents often denser fibrotic bands collagen remains within confines thyroid also characterized invasion thyroid tissue leukocytes mainly tlymphocytes rare serious complication thyroid lymphoma generally bcell type nonhodgkin diagnosis usually made detecting elevated levels antithyroid peroxidase antibodies serum seronegative without circulating autoantibodies thyroiditis also ultrasound may useful detecting hashimoto thyroiditis especially seronegative thyroiditis due key features detected ultrasound person hashimotos thyroiditis echogenicity heterogeneity hypervascularity presence small various tests chosen depending presenting symptoms patients autoimmune thyroiditis known many patients may circulating antibodies present symptoms patients may present doctors evaluation symptoms physicians often start assessing reported symptoms performing thorough physical exam including neck given relatively nonspecific symptoms initial hypothyroidism hashimotos thyroiditis often misdiagnosed depression cyclothymia premenstrual syndrome chronic fatigue syndrome fibromyalgia less frequently erectile dysfunction anxiety disorder gross examination hard goiter painful touch often symptoms seen hypothyroidism periorbital myxedema depend current state progression response especially given usually gradual development clinically relevant hypothyroidism testing thyroidstimulating hormone tsh free free antithyroglobulin antibodies antitg antithyroid peroxidase antibodies antitpo tpoab antimicrosomal antibodies help obtain accurate earlier assessment person may present elevated levels thyroglobulin owing transient thyrotoxicosis inflammation within thyroid causes damage integrity thyroid follicle storage thyroglobulin tsh secretion anterior pituitary increases response decrease negative feedback inhibition secondary decreased serum thyroid hormones typically preferred thyroid hormone test exposure body substantial amounts previously isolated thyroid enzymes thought contribute exacerbation tolerance breakdown giving rise pronounced symptoms seen later disease lymphocytic infiltration thyrocyteassociated tissues often leads histologically significant finding germinal center development within thyroid glandcitation needed hashimotos presenting mania known prasads syndrome ashok prasad psychiatrist first described initial diagnostic evaluation start plasma thyroidstimulating hormone tsh elevated signifies elevation usually marked increase normal range generally greater free levels usually lowered sometimes might doctors may check thyroglobulin antibodies tgab whenever thyroglobulin test performed see antibody interfering tgab may also ordered regular intervals person diagnosed thyroid cancer like tpoab associated hashimotos common complement lab values patients autoimmune thyroiditis high tsh low positive tpo patients normal laboratory values symptoms autoimmune thyroiditis ultrasound plays role images obtained ultrasound evaluate size thyroid support diagnosis autoimmune thyroiditis reveal presence nodules provide clues diagnosis thyroid hypothyroidism caused hashimotos thyroiditis treated thyroid hormone replacement agents levothyroxine triiodothyronine desiccated thyroid extract tablet taken day generally keeps thyroid hormone levels normal cases treatment needs taken rest persons life hypothyroidism caused hashimotos thyroiditis tsh levels may recommended kept standard care levothyroxine therapy oral medication structured like endogenous levothyroxine dosed based upon weight commonly tsh usually dose prescribed ranges mcgkg mcgkg adjusted based upon example dose may lowered elderly patients patients certain cardiac conditions increased pregnant administered consistent patients elect combination therapy levothyroxine liothyronine synthetic however studies combination therapy side effects thyroid replacement therapy associated iatrogenic symptoms watch include limited anxiety tremor weight loss heat sensitivity diarrhea shortness breath worrisome symptoms include atrial fibrillation bone density tsh laboratory value choice monitoring response treatment treatment first initiated tsh levels may monitored often frequency every time dose adjusted tsh levels may measured frequency correct dose titrated proper dose tsh levels monitored surgery initial treatment choice autoimmune indication patients generally may begin discussing surgery doctor experiencing significant pressure symptoms cosmetic concerns nodules present overt symptomatic thyroid dysfunction common complication people subclinical hypothyroidism chronic autoimmune thyroiditis progressing thyroid failure every year transient periods thyrotoxicosis overactivity thyroid sometimes occur rarely illness may progress full hyperthyroid graves disease active orbitopathy bulging inflamed eyes rare cases fibrous autoimmune thyroiditis present severe shortness breath difficulty swallowing resembling aggressive thyroid tumors symptoms always improve surgery corticosteroid therapy although primary thyroid bcell lymphoma affects fewer one persons likely affect longstanding autoimmune increased risk developing primary thyroid lymphoma patients hashimotos hashimotos thyroiditis disorder thought common cause primary hypothyroidism north within person place time descriptive trends epidemiology becomes clear hashimotos thyroiditis develops impacts differing populations overall hashimotos thyroiditis affects general caucasians develop hashimotos point us africanamerican population experiences less commonly greater associated also less frequent asian people disease occurs times often women men research suggests connection role placenta explanation sex though may occur age including children often observed women years highest prevalence one study found elderly members already autoimmune disease greater risk developing hashimotos diseases generally coexist common diseases seen coexisting hashimotos include celiac disease multiple sclerosis type diabetes vitiligo rheumatoid arthritiscitation needed congenital hypothyroidism affects newborns birth version intellectual disability treated caught early hard diagnose given symptoms minimal young congenital hypothyroidism generally caused defects thyroid gland cases europe asia africa iodine intake cause hypothyroidism newborns diets consisting low high iodine intake determine populations risk developing thyroidrelated common regions high iodine dietary intake among people genetically geography plays large role regions access diets low high iodine iodine levels water salt heavily monitored order protect atrisk populations developing geographic trends hypothyroidism vary across world different places different ways defining disease reporting cases populations spread defined poorly may skew data unexpected iodine deficiency disorder idd combated using increase iodine persons diet dramatic change occurs persons diet become atrisk developing hypothyroidism thyroid disorders combatting idd high salt intakes done carefully cautiously risk hashimotos may making modifications ones diet important use clinicians discretion ensure dietary changes best option recommendations vary person personcitation needed secular trends hypothyroidism reveal disease changed course time given changes technology treatment options even though ultrasound technology treatment options improved incidence hypothyroidism increased according data focused us europe per women disease found varying per men disease increased changes definition hypothyroidism treatment options modify incidence prevalence disease overall treatment using levothyroxine individualized therefore allows disease manageable time work cure also known hashimotos disease hashimotos thyroiditis named japanese physician hakaru hashimoto medical school kyushu first described symptoms persons struma lymphomatosa intense infiltration lymphocytes within thyroid german journal called archiv für klinische paper made pages illustrations describing histological changes thyroid tissue furthermore results first study collected four women results explained pathological characteristics observed women especially infiltration lymphoid plasma cells well formation lymphoid follicles germinal centers fibrosis degenerated thyroid epithelial cells leukocytes described traits histologically similar mikulics disease mentioned discovered traits new disease named disease struma lymphomatosa disease emphasized lymphoid cell infiltration formation lymphoid follicles germinal centers neither ever previously despite dr hashimotos discovery publication disease recognized distinct reidels thyroiditis common disease time europe although many articles reported published researchers hashimotos struma lymphomatosa recognized early phase reidels thyroiditis early disease recognized disease right researchers allen graham et al cleveland reported symptoms presentation detailed manner drs rose witebsky able demonstrate immunization certain rodents extracts rodents thyroid resembled disease hakaru researchers trying doctors also able describe antithyroglobulin antibodies blood serum samples animalscitation needed later year researchers middlesex hospital london able perform human experiments patients presented similar symptoms purified antithyroglobulin antibody serum able conclude sick patients immunological reaction human data proposed hashimotos struma could autoimmune disease thyroid gland recognized autoimmune disorder first organspecific autoimmune disorder following recognition researchers middlesex hospital published article lancet included portrait hakaru disease became well known moment hashimotos disease started appear frequently textbookscitation needed since discoveries number autoimmune diseases discovered several thyroidspecific antibodiescitation needed pregnant women positive hashimotos thyroiditis may decreased thyroid function gland may fail woman tpoabpositive clinicians inform risks infant disease goes untreated thyroid peroxidase antibodies tpoab detected pregnant women presents risks women low thyroid function stabilized greater risk infant low birth weight neonatal respiratory distress hydrocephalus hypospadias miscarriage preterm embryo transplantion rate successful pregnancy outcomes improved hashimotos recommendations treat pregnant women tpoabpositive throughout entirety pregnancies screen pregnant women thyroid close cooperation endocrinologist obstetrician benefits woman endocrine society recommends screening pregnant women considered highrisk thyroid autoimmune thyroid peroxides antibodies testing recommended women ever pregnant regardless pregnancy outcome previous pregnancy plays major role development autoimmune overt hypothyroidism premenopausal women number previous pregnancies taken account evaluating risk hypothyroidism young women hormonal changes trophoblast expression key immunomodulatory molecules lead immunosuppression fetal tolerance main players regulation immune response tregs cellmediated humoral immune responses attenuated resulting immune tolerance suppression autoimmunity reported pregnancy levels thyroid peroxidase thyroglobulin antibodies decrease giving birth tregs rapidly decrease immune responses reestablished may lead occurrence aggravation autoimmune thyroid females thyroid peroxidase antibodies early pregnancy thyroid autoimmunity postpartum period exacerbates form postpartum higher secretion ifnγ lower plasma cortisol concentration pregnancy reported females postpartum thyroiditis healthy females indicates weaker immunosuppression pregnancy could contribute postpartum thyroid several years delivery chimeric male cells detected maternal peripheral blood thyroid lung skin lymph nodes fetal immune cells maternal thyroid gland may become activated act trigger may initiate exaggerate autoimmune thyroid disease hashimotos disease patients fetal microchimeric cells detected thyroid significantly higher numbers healthy hashimotos disease also known chickens gallus rats rattus mice mus dogs canis marmosets httpsenwikipediaorgwikiautoimmunethyroiditis